FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, in particular to obstetrics, and is intended to predict preterm labor. Using indicators of the concentration of the total amount of extracellular DNA (ovDNA) and the concentration of IL-8 in peripheral blood plasma in pregnant women at 22-36 weeks of gestation, the variable P is determined. At P > 0.5, preterm labor will occur. When P ≤ 0.5, preterm labor will not occur.
EFFECT: invention provides an effective prediction of preterm labor by the joint determination of ovDNA and neutrophil-activating factor in peripheral blood plasma.
1 cl, 1 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CHORIOAMNIONITIS DEVELOPMENT IN WOMEN WITH EXACERBATION OF CYTOMEGALOVIRAL INFECTION IN THE SECOND TRIMESTER OF PREGNANCY AND THREAT OF MISCARRIAGE | 2020 |
|
RU2733168C1 |
| PROGNOSTICATION OF PRETERM DELIVERY THROUGH THE DETECTION OF CATALASE ACTIVITY IN PERIPHERAL BLOOD PLASMA | 2017 |
|
RU2645093C1 |
| METHOD FOR PREDICTION OF EARLY MISCARRIAGE | 2012 |
|
RU2501017C1 |
| METHOD OF EARLY PREDICTION OF MISCARRIAGE BY ASSESSING INTERLEUKIN 1Β AND PROSTAGLANDIN E2 IN THE BLOOD SERUM OF PREGNANT WOMEN WITH EXACERBATION OF CYTOMEGALOVIRUS INFECTION | 2023 |
|
RU2804278C1 |
| METHOD FOR PREDICTING PREMATURE BIRTH IN WOMEN WITH ISTHMIC-CERVICAL INSUFFICIENCY | 2021 |
|
RU2779363C1 |
| METHOD FOR PREDICTING IMMINENT ABORTION THREAT OCCURRENCE AND RETENTION OVER THE WHOLE GESTATION PERIOD | 2006 |
|
RU2317554C1 |
| METHOD FOR EARLY PREDICTION OF MISCARRIAGE ASSOCIATED WITH REACTIVATION OF CYTOMEGALOVIRUS INFECTION | 2022 |
|
RU2787451C1 |
| METHOD FOR PRETERM DELIVERY PREDICTION | 2016 |
|
RU2642597C1 |
| METHOD FOR PREDICTION OF PREMATURE BIRTH BY MEASURING BLOOD SERUM OF 8-ISOPROSTANE AND 12-HYDROXYEICOSATETRAENOIC ACID IN PREGNANT WOMEN WITH COVID-19 IN THE THIRD TRIMESTER | 2024 |
|
RU2821128C1 |
| METHOD FOR PREDICTING THE THREAT OF MISCARRIAGE DURING REACTIVATION OF LATENT CYTOMEGALOVIRUS INFECTION BY DETERMINING ESTRADIOL AND ESTROGEN RECEPTOR ALPHA IN BLOOD SERUM | 2021 |
|
RU2762485C1 |
